4 mg ETH 268 (Doxazosin 4 mg)
Pill imprint 4 mg ETH 268 has been identified as Doxazosin mesylate 4 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 4 mg ETH 268
- 4 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Ethex Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- hydrated alumina
sodium lauryl sulfate
sodium starch glycolate
D&C Red No. 27 Aluminum Lake
D&C Red No. 30 Aluminum Lake
|NDC Code||Manufacturer / Repackager|
|67253-0382||DAVA Pharmaceuticals, Inc.|
|54569-5170||A S Medication Solutions LLC (repackager)|
|68115-0122||Dispensexpress Inc (repackager)|
|58016-0625||Southwood Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about doxazosin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.